Creative Commons source reading · Traumatic brain injury recovery
The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.
Charles Palmer; Ally T Ferber; Brian D Greenwald
Originally published in Brain sciences · 2025-05-26
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Background: This narrative review explores psilocybin's potential use as a therapeutic agent in patients with traumatic brain injury (TBI). Methods: We engaged in a search of PubMed, ScienceDirect, and Cochrane's databases for information on the effects of psilocybin. We also reviewed articles where psilocybin was used in patients with TBI. Articles from 2000-2025 were included. Results: A total of 29 articles met our initial inclusion criteria. Additionally, 13 articles were obtained from reference lists and 3 more articles on the legality of psilocybin from public websites. Conclusions: Assisted psilocybin use may have benefits in TBI by reducing inflammation, promoting neuroplasticity and neuroregeneration, and alleviating associated mood disorders. Positive findings in related fields, like treatment for depression and addiction, highlight the necessity for more extensive clinical trials on psilocybin's role in TBI recovery.
Editorial reading guide
- How did the authors define recovery, and when did they measure it?
- Does the outcome reflect a laboratory measure, a functional change or participation in daily life?
